Table 4.
Overall survival (OS) according to baseline characteristics in patients with (−) MTb 6110.
| Characteristic | OS (95% CI) | P |
|---|---|---|
| Age | ||
| < 60 | 22.4 (10.3–34.4) | 0.57 |
| > 60 | 21.3 (0.0–62.7) | |
| Gender | ||
| Male | 7.4 (0.0–16.5) | 0.12 |
| Female | 22.4 (9.9–34.8) | |
| Smoking history | ||
| No | 15.5 (0.46–30.6) | 0.7 |
| Yes | 15.4 (0.0–30.8) | |
| Woodsmoke exposure | ||
| No | 13.8 (0.0–29.7) | 0.61 |
| Yes | 15.5 (4.2–26.8) | |
| Asbestos exposure | ||
| No | 18 (4.5–31.4) | 0.57 |
| Yes | 9.6 (2.6–16.7) | |
| ECOG | ||
| 0–1 | 20.5 (10.5–30.5) | 0.01 |
| > 2 | 6.8 (0.0–15.7) | |
| Diabetes | ||
| No | 15.5 (2.8–28.2) | 0.66 |
| Yes | 13.8 (0.0–29.7) | |
| EGFR | ||
| Wildtype | 26.5 (18.1–34.8) | 0.32 |
| Mutated | 15.5 (1.6–29.4) | |
| Histology | ||
| Adenocarcinoma | 17.9 (5.9–30.0) | 0.01 |
| Other | 2.1 (0.5–1.2) | |
| Adenocarcinoma subtype | ||
| Papillary | 22.4 (5.6–39.2) | < 0.001 |
| Acinar | 25.3 (20–30.6) | |
| Solid | 20.5 (8.8–32.2) | |
| Lepidic | 1.2 (NR) | |
| Not specified/other histology | 4.0 (1.8–6.1) | |
Significant values are in bold.